Previous 10 | Next 10 |
Galmed Pharma (NASDAQ:GLMD) is trading lower for the second straight session after H.C. Wainwright downgraded the Israel-based biotech to Neutral on Tuesday, citing, among other things, uncertainty in its research into liver disease, non-alcoholic steato-hepatitis (NASH). Commenting on a regi...
Gainers: Sonoma Pharmaceuticals (SNOA) +29%. Blue Water Vaccines (BWV) +32%. XORTX Therapeutics (XRTX) +27%. Eqonex (EQOS) +21%. TETRA Technologies (TTI) +20%. Enovix (ENVX) +18%. JAKKS Pacific (JAKK) +18%. Blue Apron Holdings (APRN) +17%. Borr Drilling (BORR) +16%. Western Digital Corp...
Gainers: Sonoma Pharmaceuticals (SNOA) +42%. XORTX Therapeutics (XRTX) +18%. Retractable Technologies (RVP) +14%. Catalent (CTLT) +12%. Field Trip Health (FTRP) +5%. Losers: Spero Therapeutics (SPRO) -61%. Semler Scientific (SMLR) -23%. Galmed Pharmaceu...
Spero Therapeutics (SPRO) -52% after announcing new strategic direction focusing on advancing promising clinical-stage pipeline. Chegg (CHGG) -40% on Q1 earnings release. Galmed Pharmaceuticals (GLMD) -19% on Q4 earnings release. Better Therapeutics (BTTX) -16%. Haywa...
Galmed Pharmaceuticals Ltd. (GLMD) Q4 2021 Earnings Conference Call May 2, 2022, 08:30 AM ET Company Participants Allen Baharaff - President and CEO Yohai Stenzler - Chief Accounting Officer Conference Call Participants Steven Seedhouse - Raymond James Kristen Kluska - Cantor Fitzgerald Naz R...
Galmed press release (NASDAQ:GLMD): Q4 GAAP EPS of -$0.30 in-line. Cash and cash equivalents, restricted cash, short-term deposits, and marketable debt securities totaled $34.9 million as of December 31, 2021, compared with $51.0 million as of December 31, 2020. For further details see: ...
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2021 Financial Results PR Newswire - Conference Call and Webcast Today at 8:30 a.m. ET / 5:30 a.m. PT - TEL AVIV, Israel , May 2, 2022 /PRNewswire/ -- Galmed Pharm...
AMG,ARLP,AUDC,AXSM,AYRO,BKCC,BRK.B,CNA,CRNT,EPD,GLMD,GPN,GPRE,INMD,ITRI,L,MCO,NGD,ON,PK,SAIA,SIX,SXC,TKR,WEC For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open
Galmed reports interim results from the Open-Label part of the ARMOR study with Aramchol showing robust fibrosis improvement across multimodality histological assessment PR Newswire - Treatment with Aramchol 300mg BID resulted in a high rate of subjects with fibrosis imp...
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2021 Financial Results and Provide Business Update on Monday May 2 PR Newswire TEL AVIV, Israel , April 26, 2022 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company...
News, Short Squeeze, Breakout and More Instantly...
Galmed Pharmaceuticals Ltd. Company Name:
GLMD Stock Symbol:
NASDAQ Market:
Galmed Pharmaceuticals Ltd. Website: